Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation

Clinical Transplantation

Volumn 25, Issue 2, 2011, Pages 283-291

  Ladabaum, Uri ^a   Cheng, Shan L ^a   Yao, Francis Y ^a   Roberts, John P ^b  

^a Division of Gastroenterology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatocellular carcinoma; Hepatoma; Liver transplantation; Screening

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MONEY; PRIORITY JOURNAL; RECURRENT CANCER; THORAX RADIOGRAPHY;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; COST-BENEFIT ANALYSIS; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79953323266     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01212.x     Document Type: Article

References (20)

1. Said A, Lucey MR. Liver transplantation: an update 2008. Curr Opin Gastroenterol 2008: 24: 339.
2. Ioannou GN, Perkins JD, Carithers RL Jr. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008: 134: 1342.
3. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996: 334: 693.
4. Regalia E, Fassati LR, Valente U et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg 1998: 5: 29.
5. Roayaie S, Schwartz JD, Sung MW et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004: 10: 534.
6. Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003: 21: 4329.
7. Yao FY, Kinkhabwala M, LaBerge JM et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005: 5: 795.
8. Nart D, Arikan C, Akyildiz M et al. Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis. Transplant Proc 2003: 35: 2986.
9. Marsh JW, Dvorchik I, Subotin M et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997: 26: 444.
10. Schlitt HJ, Neipp M, Weimann A et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999: 17: 324.
11. Schwartz M, Roayaie S, Llovet J. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol 2005: 43: 584.
12. De Carlis L, Giacomoni A, Lauterio A et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl Int 2003: 16: 115.
13. Jonas S, Bechstein WO, Steinmuller T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001: 33: 1080.
14. Leung JY, Zhu AX, Gordon FD et al. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl 2004: 10: 1343.
15. Shetty K, Timmins K, Brensinger C et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004: 10: 911.
16. Best JH, Veenstra DL, Geppert J. Trends in expenditures for Medicare liver transplant recipients. Liver Transpl 2001: 7: 858.
17. Kashef E, Yao FY, Roberts JP. Hepatocellular carcinoma. In: Yeo CJ, Dempsey DT, Klein AS, Pemberton JH, Peters JH, eds. Shackleford's Surgery of the Alimentary Tract. Philadelphia: Elsevier, 2006: 1732.
18. Llovet JM, Ricci S, Mazzaferro V et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008: 359: 378.
19. Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med 1996: 101: 422.
20. Sarasin FP, Giostra E, Mentha G, Hadengue A. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998: 28: 436.